Does N-Acetylcysteine Decrease Spontaneous Oxidation of Central Neural Dopamine in Parkinson's Disease?
Clinical trial NCT03104725 · TERMINATED
Trial details
- NCT number
- NCT03104725
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-25
- Primary completion
- 2020-02-27
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.